Perceptive Advisors Acquires 9.99% Stake in Kiora Pharmaceuticals via Private Placement

On April 13, 2026, Perceptive Advisors LLC, alongside Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., filed a Schedule 13G disclosing a new ownership stake in Kiora Pharmaceuticals, Inc. (KPRX). The reporting persons acquired 438,471 shares of Common Stock, representing a 9.99% ownership interest in the company. This acquisition occurred on April 6, 2026, through a private placement transaction conducted by the issuer. The shares are held directly by the Master Fund, while Perceptive Advisors serves as the investment manager and Joseph Edelman serves as the managing member, both of whom may be deemed to have shared voting and dispositive power over the securities. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The ownership percentage is calculated based on an aggregate of 4,389,099 shares outstanding following the private placement.